Physician profile
Randy K Brown
NPI 1629067202
$3,014.79
in general payments reported to CMS, 2019-2025
12 companies · $14.23 in 2025
The $14.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.71 · 2021: $48.60 · 2022: $2,845 · 2023: $82.10 · 2024: $13.32 · 2025: $14.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,800.00 | 2022 | |
| Lilly USA, LLC | $49.24 | 2021-2022 | |
| Abbvie INC. | $27.55 | 2024-2025 | |
| Alkermes, INC. | $24.16 | 2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.21 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $19.97 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.35 | 2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $14.42 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.59 | 2022 | |
| Mdd US Operations, LLC | $11.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.63 | 2021 | |
| Corium, LLC | $5.96 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.